chr14-24241772-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001099274.3(TINF2):āc.302A>Gā(p.Lys101Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001099274.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TINF2 | NM_001099274.3 | c.302A>G | p.Lys101Arg | missense_variant | 3/9 | ENST00000267415.12 | NP_001092744.1 | |
TINF2 | NM_001363668.2 | c.197A>G | p.Lys66Arg | missense_variant | 2/8 | NP_001350597.1 | ||
TINF2 | NM_012461.3 | c.302A>G | p.Lys101Arg | missense_variant | 3/6 | NP_036593.2 | ||
TINF2 | XM_011536642.3 | c.302A>G | p.Lys101Arg | missense_variant | 3/5 | XP_011534944.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TINF2 | ENST00000267415.12 | c.302A>G | p.Lys101Arg | missense_variant | 3/9 | 1 | NM_001099274.3 | ENSP00000267415 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248818Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134960
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461558Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727030
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 21, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | TINF2: PM2:Supporting, BP4 - |
Dyskeratosis congenita Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 25, 2022 | This variant has not been reported in the literature in individuals affected with TINF2-related conditions. ClinVar contains an entry for this variant (Variation ID: 529182). This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 101 of the TINF2 protein (p.Lys101Arg). This variant is present in population databases (no rsID available, gnomAD 0.007%). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | curation | Sema4, Sema4 | Jul 16, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at